Biotech Values

[DewDiligence]

Interesting IDIX insider transaction reported today:

Two days ago (11/11/09), David Standring, EVP of Biology, exercised 15,000 options and has retained the 15,000 shares, at least for the time being. The options in question did not expire until Sep 2010, so Standring was under no pressure to exercise them now.

An exercise-and-hold action by a corporate insider is one of the most bullish signals an insider can give. Unlike purchases on the open market, insiders may legally exercise options even when they are in possession of material non-public information such as a pending partnership deal.

In this case, the bullishness of the signal must be tempered by the fact that the amount in question is relatively small.